XOOMAR

Leidos Holdings (LDOS)

Leidos Holdings on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, federal contracts, earnings dates and insider trades. Listed on NYSE, classified by the SEC as services-computer integrated systems design.

Download CSV

4.8M

Short interest

settlement 2026-09-30

3.5

Days to cover

-0.9 days vs prior

29.6%

Short share of volume

2026-10-14

27

Fails to deliver

settlement 2026-09-08

Tue 3 Nov

Next earnings

estimated date

-$1.5M

Insider flow, 90 days

0 buys, 3 sells

As of 2026-10-14.

Short interest

FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in LDOS is 4,783,477 shares, up 1,159,893 shares over the last month. Over the last 48 readings it ranged from 1,408,968 shares (15 October 2024) to 6,413,623 shares (15 July 2026). At the reported average volume of 1.4M shares a day that is 3.5 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ldos" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-09-304,783,477-8.7%1,363,5403.51
2026-09-155,236,432+44.5%1,198,4714.37
2026-08-313,623,584-13.7%1,072,7653.38
2026-08-144,197,413-19.3%1,964,7052.14
2026-07-315,200,289-18.9%1,416,4843.67
2026-07-156,413,623+10.9%1,443,1794.44
2026-06-305,780,627+31.9%2,622,1472.20
2026-06-154,381,493-7.5%1,284,7073.41
2026-05-294,734,270+6.7%1,291,8143.66
2026-05-154,436,868+34.5%1,700,1272.61
2026-04-303,300,026-5.3%816,4644.04
2026-04-153,483,444-4.0%796,2324.37
2026-03-313,628,171-3.6%1,272,8092.85
2026-03-133,764,705+25.3%1,182,4023.18
2026-02-273,004,079+9.4%1,558,2871.93
2026-02-132,744,956+2.2%988,5212.78
2026-01-302,685,683+10.4%787,7183.41
2026-01-152,431,645+6.6%1,086,3182.24
2025-12-312,282,009-13.1%769,9762.96
2025-12-152,626,420+19.8%828,9493.17
2025-11-282,192,916-8.3%782,2112.80
2025-11-142,392,543-0.6%910,9282.63
2025-10-312,407,933-9.2%708,4613.40
2025-10-152,651,512-4.7%739,2473.59

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 14 October 2026, the short share of LDOS volume is 29.6%, down 6.6 points over the last five sessions. Over the last 30 readings it ranged from 29.6% (14 October 2026) to 68.5% (29 September 2026). The latest reading sits at the bottom of that range. The latest reading is 22.0 points below the 30-session average of 51.6%, on 303K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-10-1490K303K29.6%30
2026-10-13176K378K46.7%0
2026-10-12104K272K38.1%38
2026-10-09177K396K44.6%16
2026-10-08317K702K45.1%5,038
2026-10-07197K543K36.3%9
2026-10-06250K480K52.1%5
2026-10-05212K413K51.5%95
2026-10-02207K367K56.3%45
2026-10-01193K417K46.1%442
2026-09-30178K337K52.7%281
2026-09-29299K437K68.5%120
2026-09-28210K350K60.1%1,010
2026-09-25182K371K48.9%190
2026-09-24179K345K51.9%0
2026-09-23191K366K52.3%0
2026-09-22223K374K59.6%173
2026-09-21254K410K62.0%68
2026-09-18213K331K64.2%171
2026-09-17182K315K57.8%78
2026-09-16244K439K55.6%64
2026-09-15196K407K48.1%882
2026-09-14278K430K64.6%25
2026-09-11246K442K55.7%65
2026-09-10235K387K60.9%1,072
2026-09-09211K381K55.3%17,334
2026-09-08261K503K51.8%10,134
2026-09-04170K413K41.2%89
2026-09-03184K406K45.5%167
2026-09-02176K385K45.9%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 8 September 2026, the fails-to-deliver balance in LDOS is 27 shares, down 1,489 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (27 July 2026) to 19,553 shares (13 May 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-09-0827$133.05$4K
2026-08-241,516$141.39$214K
2026-08-131,386$140.38$195K
2026-08-12339$140.89$48K
2026-08-11665$139.10$93K
2026-08-10500$137.57$69K
2026-08-07500$135.26$68K
2026-08-04203$118.72$24K
2026-07-285,147$114.95$592K
2026-07-272$112.14$224
2026-07-234$107.26$429
2026-07-20513$106.48$55K
2026-07-1788$108.29$10K
2026-07-0235$103.07$4K
2026-05-1421$124.17$3K
2026-05-1319,553$128.39$2.5M
2026-04-16111$159.04$18K
2026-04-153$156.17$469
2026-03-266,583$158.88$1.0M
2026-03-2513$158.99$2K
2026-03-245$162.54$813
2026-03-134,877$173.81$848K
2026-03-11288$172.51$50K
2026-03-102,350$179.54$422K
2026-02-277,733$175.86$1.4M
2026-02-23158$173.50$27K
2026-02-20153$176.27$27K
2026-02-116,196$194.72$1.2M
2026-02-0445$189.79$9K
2026-01-2929$187.77$5K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

Insiders at LDOS reported 3 open-market sells worth $1.5M in the last 90 days and no open-market buys. Latest filing: KRAEMER HARRY M JANSEN JR (Director) on 2026-10-07.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-10-07KRAEMER HARRY M JANSEN JRDirectorGrant297$0.00$0132K
2026-09-30Stevens Roy ESector PresidentGrant6$0.00$02K
2026-09-30KRAEMER HARRY M JANSEN JRDirectorGrant463$0.00$0132K
2026-09-30Cage Christopher RChief Financial OfficerGrant93$0.00$032K
2026-09-30Antal Daniel J.EVP, General CounselGrant5$0.00$011K
2026-09-30SHAPARD ROBERT SDirectorGrant6$0.00$02K
2026-09-01May Gary StephenDirectorSell1K$140.85$141K10K
2026-08-11Geer Noel BDirectorSell2K$141.07$212K34K
2026-08-11Geer Noel BDirectorSell9K$140.59$1.2M36K
2026-08-04Porter Elizabeth ASector PresidentTax withholding5K$118.72$605K44K
2026-08-04Stevens Roy ESector PresidentTax withholding5K$118.72$544K58K
2026-08-04Cage Christopher RChief Financial OfficerTax withholding5K$118.72$544K60K
2026-07-06KRAEMER HARRY M JANSEN JRDirectorGrant310$0.00$0131K
2026-06-30SHAPARD ROBERT SDirectorGrant7$0.00$02K
2026-06-30Stevens Roy ESector PresidentGrant8$0.00$02K
2026-06-30KRAEMER HARRY M JANSEN JRDirectorGrant565$0.00$0131K
2026-06-30Cage Christopher RChief Financial OfficerGrant113$0.00$032K
2026-06-30Antal Daniel J.EVP, General CounselGrant6$0.00$011K
2026-05-08May Gary StephenDirectorGrant1K$0.00$011K
2026-05-08Norton Nancy ADirectorGrant1K$0.00$03K
2026-05-08Shanahan Patrick MDirectorGrant1K$0.00$06K
2026-05-08SHAPARD ROBERT SDirectorGrant1K$0.00$060K
2026-05-08KRAEMER HARRY M JANSEN JRDirectorGrant1K$0.00$0130K
2026-05-08Jonas Tina WDirectorGrant1K$0.00$02K
2026-05-08Geer Noel BDirectorGrant1K$0.00$044K
2026-05-08Fubini David GDirectorGrant1K$0.00$018K
2026-05-08Dahlberg Gregory RDirectorGrant1K$0.00$024K
2026-05-07May Gary StephenDirectorSell1K$132.75$197K10K
2026-05-07May Gary StephenDirectorTax withholding2K$134.90$251K12K
2026-05-07May Gary StephenDirectorOption exercise3K$75.02$251K13K
2026-05-05Bell Thomas ArthurCEOTax withholding3K$148.81$376K109K
2026-05-03Antal Daniel J.EVP, General CounselGrant9$0.00$011K
2026-05-03Antal Daniel J.EVP, General CounselGrant9$0.00$011K
2026-05-03Antal Daniel J.EVP, General CounselTax withholding18$149.23$3K11K
2026-05-03Antal Daniel J.EVP, General CounselTax withholding188$149.23$28K14K
2026-05-01KRAEMER HARRY M JANSEN JRDirectorGrant10$0.00$0129K
2026-05-01KRAEMER HARRY M JANSEN JRDirectorGrant10$0.00$0129K
2026-04-10KRAEMER HARRY M JANSEN JRDirectorGrant221$0.00$0129K
2026-04-10KRAEMER HARRY M JANSEN JRDirectorGrant221$0.00$0129K
2026-04-07Porter Elizabeth ASector PresidentSell85$159.32$14K49K
2026-04-07Porter Elizabeth ASector PresidentSell2K$158.75$304K50K
2026-03-31Antal Daniel J.EVP, General CounselGrant3$0.00$011K
2026-03-31Stevens Roy ESector PresidentGrant5$0.00$02K
2026-03-31KRAEMER HARRY M JANSEN JRDirectorGrant364$0.00$0129K
2026-03-31SHAPARD ROBERT SDirectorGrant5$0.00$02K
2026-03-31SHAPARD ROBERT SDirectorGrant5$0.00$02K
2026-03-31Stevens Roy ESector PresidentGrant5$0.00$02K
2026-03-31KRAEMER HARRY M JANSEN JRDirectorGrant364$0.00$0129K
2026-03-31Cage Christopher RChief Financial OfficerGrant74$0.00$032K
2026-03-31Antal Daniel J.EVP, General CounselGrant3$0.00$011K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

6 Form 144 notices on file for LDOS worth $3.2M at the prices reported; 2 in the last 90 days worth $1.5M. Latest: May Gary Stephen filed on 2026-09-01 to sell 1,000 shares ($141K) from 2026-09-01.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-09-01May Gary StephenDirector1K$141K0.001%2026-09-01Citigroup Global Markets, Inc.
2026-08-11Noel B. GeerDirector10K$1.4M0.008%2026-08-11Robert W. Baird & Co.
2026-05-07May Gary StephenDirector1K$197K0.001%2026-05-07Citigroup Global Markets, Inc
2026-04-07Porter Elizabeth ASector President2K$318K0.002%2026-04-07Citigroup Global Markets, Inc.
2026-01-20Porter Elizabeth APresident, Health and Civil Sector3K$584K0.002%2026-01-20Citigroup Global Markets, Inc.
2025-12-19Porter Elizabeth AOfficer, President, Health and Civil Sector3K$544K0.002%2025-12-19Citigroup Global Markets, Inc.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

1 holder reports 5% or more of LDOS in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (9,491,606 shares), filed 2026-04-30 for an event on 2026-03-31.

FiledFormHolderSharesOf classEvent
2026-04-3013GVanguard Capital Managementinvestment adviser9.5M7.5%2026-03-31
2026-03-2713G/Ano. 12The Vanguard Groupinvestment adviser00.0%2026-03-13

13F holders

Tracked managers holding LDOS at their latest 13F. JSON

7 of the 30 tracked managers held LDOS at their latest 13F, $250.3M in total at quarter-end prices. AQR Capital Management is the largest at $83.5M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 4 cut.

FundQuarterSharesValueOf portfolioChange in shares
AQR Capital Management2026-06-30827K$83.5M0.03%-46K
Citadel Advisors2026-06-30614K$63.2M0.01%+228K
Millennium Management2026-06-30604K$62.2M0.02%+238K
Two Sigma Investments2026-06-30184K$19.0M0.01%-83K
Bridgewater Associates2026-06-30159K$16.3M0.07%+157K
D. E. Shaw & Co.2026-06-3056K$5.8M0.00%-437K
Fisher Asset Management2026-06-304K$365K0.00%-3K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 FY 2026 (quarter ended 2026-07-03) Leidos Holdings reported revenue of $4.55B, up 7.4% from the same quarter a year earlier, and net income of $354.0M (2.81 diluted EPS). In FY 2025 it generated $1.75B of operating cash flow and spent $400.0M on buybacks. As of 2026-07-03, cash was $748.0M against $22.0M of debt.

Cash
$748.0M
Debt
$22.0M
Equity
$5.28B
Total assets
$15.63B
Shares outstanding
125,492,209

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q2 FY 20262026-07-03$4.55B$354.0M7.8%2.81
Q1 FY 20262026-04-03$4.38B$328.0M7.5%2.56
Q4 FY 2025derived2026-01-02$4.20B$327.0M7.8%n/a
Q3 FY 20252025-10-03$4.45B$367.0M8.2%2.82
Q2 FY 20252025-07-04$4.23B$391.0M9.2%3.01
Q1 FY 20252025-04-04$4.23B$363.0M8.6%2.77
Q4 FY 2024derived2025-01-03$4.35B$284.0M6.5%n/a
Q3 FY 20242024-09-27$4.17B$364.0M8.7%2.68

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252026-01-02$17.11B$1.45B$1.75B$125.0M$400.0Mn/a
FY 20242025-01-03$16.58B$1.25B$1.44B$149.0M$850.0Mn/a
FY 20222023-12-29$15.34B$199.0M$1.19B$207.0M$225.0Mn/a
FY 20212022-12-30$14.29B$685.0M$992.0M$129.0M$0n/a
FY 20202021-12-31$13.62B$753.0M$1.03B$104.0M$237.0Mn/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-07-03; shares outstanding as of 2026-07-28 from the cover page.

Federal contracts

The largest contract actions for Leidos Holdings and its subsidiaries. JSON

164 contract actions on file for LDOS: $2.29B obligated in the last 90 days and $2.69B in the last 12 months across 14 awarding agencies. The largest was $342.2M from the Department of Health and Human Services on 2026-09-30 (nci operational task order, fy26-fy27). This covers the largest contract actions, not every award, and agencies report late.

Action dateAgencyAmountTypeDescription
2026-09-30Department of Health and Human ServicesNational Institutes of Health$342.2Mmod P00014delivery orderNCI OPERATIONAL TASK ORDER, FY26-FY27USAspending
2026-09-30General Services AdministrationFederal Acquisition Service$15.3Mmod P00006definitive contractFUNDING MODUSAspending
2026-09-30Department of Homeland SecurityU.S. Immigration and Customs Enforcement$15.2Mnew awardbpa callIMMIGRATION & CUSTOMS ENFORCEMENT(ICE) ELECTRONIC HEALTH RECORDS BLANKET PURCHASE AGREEMENT(BPA) CALL #1 TO BUILD AN ELECTRONIC HEALTH RECORDS SYSTEM TO BE USED BY ICE FOR HEALTH RECORDS MANAGEMENT.USAspending
2026-09-29Social Security AdministrationSocial Security Administration$242.1Mmod P00030delivery orderTHE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION YEAR 5, ADD AN OPTION YEAR 5 TRAVEL CLIN, ADD AN OPTION YEAR 5 FFP CLIN, ADD THREE NEW REQUIREMENTS, AND UPDATE THE PRICING TABLE.USAspending
2026-09-29Department of Health and Human ServicesNational Institutes of Health$72.2Mnew awarddelivery orderFUNCTIONAL PRECISION MEDICINE AND RESPONSE ASSAYSUSAspending
2026-09-29General Services AdministrationFederal Acquisition Service$33.1Mmod P00056delivery orderCEILING INCREASE, ROLLOVER OY2 FUNDING, PROVIDE FUNDING FOR OY3 & NSUSAspending
2026-09-29General Services AdministrationFederal Acquisition Service$19.9Mmod P00069delivery orderTHE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND OY4 CLINS, DE-OBLIGATE FUNDS FROM OY2 AND OY3 CLINS AND RE-OBLIGATE THEM TO OY4 CLINS, REALIGN FUNDING IN OY3 AND OY4 CLINS, AND INCORPORATE ADMINISTRATIVE CHANGES TO THE TASK ORDER.USAspending
2026-09-29Department of Homeland SecurityOffice of Procurement Operations$3.8Mmod P00015delivery orderTHE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 2.USAspending
2026-09-28Department of JusticeBureau of Alcohol, Tobacco, Firearms and Explosives Acquisition and Property Management Division$9.5Mmod P00196delivery orderESA V MANAGED SERVICES (ATF AND FCS)USAspending
2026-09-28Department of Homeland SecurityFederal Law Enforcement Training Center$8.9Mnew awarddefinitive contractSTUDENT ADMINISTRATION AND SCHEDULING SYSTEM (SASS) PROJECT MANAGEMENT.USAspending
2026-09-27Department of JusticeOffices, Boards and Divisions$3Kmod P00004delivery orderINTRANET QUORUM SOFTWARE MAINTENANCE & SUPPORTUSAspending
2026-09-27Department of JusticeOffices, Boards and Divisions$0mod P00001delivery orderJMD FOIA SUPPORT SERVICESUSAspending
2026-09-27Department of JusticeOffices, Boards and Divisions$0new awardpurchase orderIQ LEDIOS RENEWAL EO 14398USAspending
2026-09-25Department of Health and Human ServicesNational Institutes of Health$60.1Mmod P00003delivery orderNIAID DCR FY26-27 OPERATIONAL TASK ORDERUSAspending
2026-09-25General Services AdministrationFederal Acquisition Service$14.4Mmod P00023delivery orderDCPDS SOFTWARE SUSTAINMENT SUPPORT SERVICES MOD 23 OY3 EXERCISEUSAspending
2026-09-25Department of Health and Human ServicesNational Institutes of Health$11.7Mnew awarddelivery orderPALM004: AN OBSERVATIONAL STUDY OF THE NATURAL HISTORY OF BUNDIBUGYO VIRUS DISEASEUSAspending
2026-09-25Department of Health and Human ServicesNational Institutes of Health$7.6Mmod P00004delivery orderTHE NIAID DIR FY26-27 OPERATIONAL TASK ORDERUSAspending
2026-09-25Department of Health and Human ServicesNational Institutes of Health$5.7Mmod P00003delivery orderNIAID / CHILDRENS NATIONAL MEDICAL CENTER JOINT CLINICAL RESEARCH PROGRAM (JCRP) IMMUNOLOGIC AND INFECTIOUS DISEASES CLINICAL RESEARCHUSAspending
2026-09-24National Aeronautics and Space AdministrationNational Aeronautics and Space Administration$25.4Mmod P00075definitive contractCARGO MISSION CONTRACT 4 (CMC4) FUNDING CORRECTIONUSAspending
2026-09-24Department of Health and Human ServicesNational Institutes of Health$17.7Mnew awarddelivery orderCLINICAL MATERIAL TECHNOLOGY DEVELOPMENT AND PILOT MANUFACTURINGUSAspending
2026-09-23National Science FoundationNational Science Foundation$149.8Mmod P00186definitive contractSCIENCE OPERATION AND MAINTENANCE SUPPORT FOR THE UNITED STATES ANTARCTIC PROGRAM. MOD 186, FY27 ANNUAL PROGRAM PLANUSAspending
2026-09-23Department of Health and Human ServicesNational Institutes of Health$2.4Mmod P00004delivery orderNCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIESUSAspending
2026-09-23Department of Health and Human ServicesNational Institutes of Health$1.8Mmod P00014delivery orderCMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTSUSAspending
2026-09-23Department of Health and Human ServicesNational Institutes of Health$1.7Mnew awarddelivery orderINTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATESUSAspending
2026-09-23National Aeronautics and Space AdministrationNational Aeronautics and Space Administration$1.6Mmod P00074definitive contractCARGO MISSION CONTRACT 4 (CMC4) FUNDING CORRECTIONUSAspending
2026-09-22Department of Homeland SecurityTransportation Security Administration$35.4Mmod P00031definitive contractTHIS MODIFICATION ADDS FUNDING TO CLINS 2001, 2002, 2003, AND 2006. THIS MODIFICATION ALSO REALIGNS FUNDING FROM CLIN 2005 TO 2001.USAspending
2026-09-22Department of TransportationFederal Aviation Administration$16.6Mmod P00067definitive contractTHE PURPOSE OF THIS MODIFICATION IS TO OBLIGATE ADDITIONAL FUNDING FOR LIFEFLIGHT OF MAINE AND VARIOUS TASK ORDER AWARDS AND REVISIONS AS NOTED IN THE LINE ITEM DESCRIPTIONS BELOW, IN ADDITION TO REALLOCATING FUNDING FOR ERAM/ERIDS SLE.USAspending
2026-09-22Department of Health and Human ServicesNational Institutes of Health$6.4Mmod P00013delivery orderCHILDHOOD CANCER RESEARCH AND CCDSFUSAspending
2026-09-22General Services AdministrationFederal Acquisition Service$2.8Mmod P00005definitive contractFUNDING AND UPDATING OF CONTRACT ATTACHMENTS.USAspending
2026-09-21Department of EnergyDepartment of Energy$13.0Mmod P00259definitive contractRESEARCH SUPPORT SERVICES (RSS), MODIFICATION P00259, INCREMENTAL FUNDING, UPDATE B.5USAspending
2026-09-18General Services AdministrationFederal Acquisition Service$41.0Mmod P00071definitive contractTHE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE AND OBLIGATE FUNDING, AND UPDATE SECTIONS B.8, AND J.1.USAspending
2026-09-18Department of EnergyDepartment of Energy$2.4Mmod P00258definitive contractIRA RESEARCH SUPPORT SERVICES (RSS), MODIFICATION P00258, INCREMENTAL FUNDING, UPDATE B.5USAspending
2026-09-17General Services AdministrationFederal Acquisition Service$9.8Mmod P00023delivery orderARMY GLOBAL UNIFIED NETWORK INCREMENT 1 AGUNUSAspending
2026-09-17Department of Health and Human ServicesNational Institutes of Health$5.3Mmod P00014delivery orderHHSN261201500003I HHSN26100071 400.021.0071.0001 NCI CBIIT APPROPRIATED EXPAND DATA COMMONS 09/14/18-09/13/2025USAspending
2026-09-17Department of Health and Human ServicesNational Institutes of Health$4.2Mmod P00013delivery orderCMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTSUSAspending
2026-09-17Department of JusticeBureau of Alcohol, Tobacco, Firearms and Explosives Acquisition and Property Management Division$3.6Mmod P00195delivery orderESA V MANAGED SERVICES (ATF AND FCS)USAspending
2026-09-16General Services AdministrationFederal Acquisition Service$13.8Mmod P00068delivery orderTHE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE OY2 FUNDING, DE-OBLIGATE OY3 FUNDING, PROVIDE INCREMENTAL FUNDING TO OY4, REALLOCATE OY4 FUNDING, RE-OBLIGATE FUNDING TO OY4, AND INCORPORATE ADMINISTRATIVE CHANGES.USAspending
2026-09-15Department of Health and Human ServicesNational Institutes of Health$27.6Mmod P00009delivery orderNICHD: NON-R&D: ERA AGILE SOFTWARE DEVELOPMENT SUPPORT SERVICES: SEVERABLEUSAspending
2026-09-15Department of Homeland SecurityU.S. Customs and Border Protection$8.0Mmod P00013delivery orderTO EXERCISE OPTION AND EXTEND THE ORDER FOR 30 DAYS.USAspending
2026-09-15Department of Health and Human ServicesNational Institutes of Health$4.5Mnew awarddelivery orderNCI-ARCDCTD-26-0055 - CPTAC BIOSPECIMEN ACQUISITION, PROCESSING, AND DISTRIBUTIONUSAspending

What this page is

Leidos Holdings in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Leidos Holdings (LDOS), SEC CIK 1336920, listed on NYSE, classified by the SEC as services-computer integrated systems design. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-14.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-08.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-01.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-30.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials
SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-07-03.JSON and CSV
Federal contracts
USAspending.govSource: USAspending.gov.The largest contract actions each day, as agencies report them (up to 90 days late). Latest 2026-09-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-04.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-07.JSON and CSV
Company record
EDGAR filing index for CIK 1336920Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of LDOS is sold short?
4,783,477 shares were held short at the 2026-09-30 settlement, 3.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is LDOS's daily short volume?
On 2026-10-14, 89,614 of the 302,614 LDOS shares reported to FINRA were sold short, 29.6% of the day's reported volume. Short volume is a flow for one day, not a position.
Does LDOS have fails to deliver?
The SEC's latest file shows 27 LDOS shares failed to deliver at settlement 2026-09-08. Fails are reported per settlement date and published twice a month with a lag.
Are LDOS insiders buying or selling?
Insiders at LDOS reported 3 open-market sells worth $1.5M in the last 90 days and no open-market buys. Latest filing: KRAEMER HARRY M JANSEN JR (Director) on 2026-10-07.
Have LDOS insiders filed to sell?
6 Form 144 notices on file for LDOS worth $3.2M at the prices reported; 2 in the last 90 days worth $1.5M. Latest: May Gary Stephen filed on 2026-09-01 to sell 1,000 shares ($141K) from 2026-09-01.
Who owns 5% or more of LDOS?
1 holder reports 5% or more of LDOS in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (9,491,606 shares), filed 2026-04-30 for an event on 2026-03-31.
What did LDOS report last quarter?
In Q2 FY 2026 (quarter ended 2026-07-03) Leidos Holdings reported revenue of $4.55B, up 7.4% from the same quarter a year earlier, and net income of $354.0M (2.81 diluted EPS). In FY 2025 it generated $1.75B of operating cash flow and spent $400.0M on buybacks. As of 2026-07-03, cash was $748.0M against $22.0M of debt.
Which tracked 13F managers own LDOS?
7 of the 30 tracked 13F managers held LDOS shares at their latest filing, $250.3M in all. The largest: Cliff Asness's AQR Capital Management (827K shares, $83.5M), Ken Griffin's Citadel Advisors (614K shares, $63.2M), Izzy Englander's Millennium Management (604K shares, $62.2M), Two Sigma Investments (184K shares, $19.0M), Ray Dalio's Bridgewater Associates (159K shares, $16.3M), D. E. Shaw & Co. (56K shares, $5.8M). The table above lists all 7.
How much federal contract money did LDOS receive?
$2.29B was obligated to Leidos Holdings and its subsidiaries in the last 90 days and $2.69B in the last 12 months, counting the largest contract actions on USAspending, not every award. Obligations are not revenue; they are spent over each contract's life.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.